Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B1XN
|
|||
Former ID |
DNC014785
|
|||
Drug Name |
5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid
|
|||
Synonyms |
CHEMBL222717
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H16O4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C4=CC=C(O4)C(=O)O
|
|||
InChI |
1S/C24H16O4/c25-23(19-4-2-1-3-5-19)20-12-8-17(9-13-20)16-6-10-18(11-7-16)21-14-15-22(28-21)24(26)27/h1-15H,(H,26,27)
|
|||
InChIKey |
UKLDRYNCWUIPPD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Creatine kinase (CK) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | NMR screening applied to the fragment-based generation of inhibitors of creatine kinase exploiting a new interaction proximate to the ATP binding s... J Med Chem. 2007 Apr 19;50(8):1865-75. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.